News centre | United Kingdom

Feb 12, 2019

Rutherford Diagnostics and Philips Agree 10 Year Partnership to Improve Diagnostic Services and Patient Outcomes across England

Partnership to utilise innovative technology to increase access to diagnostic services with five new community sites across England

  • Agreement aims to deliver first class, patient-centred diagnostic services  

Guildford, the UKRoyal Philips (NYSE: PHG, AEX: PHIA) a leading global health technology company has announced the contract signing for a 10-year partnership with Rutherford Diagnostics. This collaboration will utilise Philips innovative radiology technology and Rutherford Diagnostics’ clinical expertise to deliver advanced diagnostic services, driving the best possible healthcare outcomes for patients. 

The agreement has a term of 10-years and the two organisations will work in partnership to deliver advanced diagnostics services, through five new diagnostics centres across the UK. Under the terms of the agreement, which is built around a Managed Technology Service, Philips will deliver: state-of-the-art imaging equipment provision; management and technology utilisation reporting; continuous training; and a research and innovation programme. For Philips, a successful managed service uses technology as an enabler to drive improved clinical practices and patient outcomes through innovation and sustainability.

Philips first managed service agreement with a private partner

“Our mission at Philips is to improve people’s lives,” says Stephen McMillan, Solutions Lead for Philips in the UK.” We believe this partnership with Rutherford Diagnostics is an opportunity to deliver a truly patient-centric diagnostic service with high levels of staff satisfaction. Philips already has a number of innovative managed service agreements with NHS partners here in the UK, so this is an exciting expansion of this service for us, as we partner with our first private provider.”

Philips and Rutherford Diagnostics will help expand access to diagnostic services for local patients in a cost-effective way that supports the best possible patient outcomes and experiences.

“ Our focus is to change the current healthcare paradigm from a reactive model which responds to disease, to one that is proactive and preventative with far reaching long-term benefits”, comments Dr Steven Powell – Chief Executive Officer of Rutherford Diagnostics. “We required  a strategic partner who will  complement our diagnostic service offering with technological innovation, Philips is closely aligned to our vision and can manage complexity while remaining flexible.  Philips is the right partner to support us on this journey.”

The first three community diagnostic centres are due to go live in 2020, with the remaining two in 2021. The first site is expected to welcome patients in Liverpool in 2020.

To find out more about Philips managed service agreements please visit Philips website here.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at

Click here to read moreClick here to read less

You are about to visit a Philips global content page


Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.